Sleep Disorders

Implantable Device Approved for Moderate-to-Severe Central Sleep Apnea

Implantable Device Approved for Moderate-to-Severe Central Sleep Apnea

By

After 6 months of use, over half of patients who used the Remedē System experienced a 50% or greater reduction in the apnea-hypopnea index.

Sleep Disordered Breathing and Risk of Cognitive Impairment Linked

Sleep Disordered Breathing and Risk of Cognitive Impairment Linked

Data from 200 participants were analyzed to determinet he link between sleep disordered breathing, cognitive function, and cognitive impairment.

Sign Up for Free e-newsletters